The largest database of trusted experimental protocols

5 protocols using apelin

1

Biomarker Profiling for Pathophysiology

Check if the same lab product or an alternative is used in the 5 most similar protocols
We examined these multidimensional biomarkers to determine the underlying pathophysiological mechanisms, including P3NP, HtrA1, apelin, and Hsp72. According to the manufacturer’s instructions, plasma P3NP (Wuhan Fine Biotech Co., Ltd., Wuhan. China), HtrA1 (Cloud-Clone Corp., Houston, TX, USA), apelin (Phoenix Pharmaceuticals, Belmont, CA, USA, and Hsp72 (Enzo Life Science Inc., Farmingdale, NY, USA) were performed using a competitive enzyme-linked immunoassay (ELISA). The lower detection limit was 156 pg/mL for P3NP, 31.2 pg/mL for HtrA1, 70 pg/mL for apelin and 200 pg/mL for Hsp72. During the sample analysis period, the variation of these assays ranged from 5 to 10%.
+ Open protocol
+ Expand
2

HepG2 Cell Culture and Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
HepG2 cells were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA). This immortalized, stable cell line can be repeatedly frozen, thawed and propagated. HepG2 cells were seeded (2×106 cells/well) in vented T-75 flasks and grown to confluence in Dulbecco’s Modified Eagle Medium (DMEM), supplemented with 50 U/ml penicillin, 50 µg/ml streptomycin and 10% of fetal calf serum (FCS). Thereafter, cells were switched to 1% FCS and incubated (37°C) under normoxic (21% O2, 5% CO2) or hypoxic conditions (5% O2, 5% CO2) in a controlled O2 water-jacketed CO2 incubator (Forma Scientific Series II, 3131, Marietta, OH) or treated with TNF-α (10 ng/ml, Sigma, St Louis, MO), lipopolysaccharide (LPS, 10 ng/ml, Sigma), AII (80 pM, Sigma), Endothelin-1 (2 nM, Sigma), Apelin (100 nM, Phoenix Pharmaceuticals, Burlingane, Ca), Fibronectin (10 ng/ml, Sigma), Interleukin-1β (20 ng/ml, Sigma) and TGF-β (10 ng/ml, R&D Systems, Minneapolis, Mn). All experiments carried out in cell lines were reproduced three times in at least 2 independent assays. Conditioned media were harvested, concentrated (80∶1) using 3000 MW Amicon Ultra centrifugal filters (Millipore Corp) and the presence of the fibrinogen α C-chain was assessed by SELDI-TOF-MS as described above.
+ Open protocol
+ Expand
3

Angiogenic factors promote lymphangiogenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Groups of three C57BL/6 mice were injected subcutaneously with 0.25 ml Matrigel (BD Biosciences) containing PBS, 0.25 μg bFGF (Eubio), or 0.25 μg apelin (Phoenix Pharmaceuticals). One week after implantation, the plug was removed, and cryosections (5 μm) were prepared for immunohistochemistry. After labeling with rabbit anti-mouse LYVE-1 and rhodamine-conjugated goat anti-rabbit IgG (purchased from ReliaTech, Braunschweig, Germany and Jackson ImmunoResearch Inc., West Grove, PA, respectively), sections were examined using a Nikon Eclipse 80i microscope and digital images were captured using a SPOT digital camera (Diagnostic Instruments, Sterling Heights, MI). Quantitative analyses of the LYVE-1-positive lymphatic vessels in the Matrigels were performed using ImageJ software.
+ Open protocol
+ Expand
4

Apelin Protects HEI-OC1 Cells from Cisplatin-Induced Injury

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEI-OC1 cells were cultured as described previously [20] . Cisplatin (P4394, Sigma-Aldrich) was used at a concentration of 30 μM because this concentration caused apoptosis and injury in HEI-OC1 cells and HCs. HEI-OC1 cells were pretreated with varying concentrations of Apelin (057-18, Phoenix Pharmaceuticals) for 2 h followed by Cisplatin treatment. Cells were then used for the designated experiments.
+ Open protocol
+ Expand
5

Apelin and Ang (1-7) Modulation of Isoproterenol-Induced Cardiac Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
The rats were randomly divided into eight groups (n=7 per group):

Group I: Control I (0.9% normal saline, IP) for 10 days,

Group II: Control II (0.9% normal saline) via a mini-osmotic pump (Alzet 2001, Cupertino, CA) implanted subcutaneously between the scapula for 10 days,

Group III: ISO (5 mg/kg, IP),

Group IV: Apelin (20 µg/kg, IP) (11 (link)),

Group V: Ang (l–7) (30 µg/kg/day via a mini-osmotic pump) (17 (link)),

Group VI: ISO (5 mg/kg, IP)+Apelin (20 µg/kg, IP),

Group VII: ISO (5 mg/kg, IP)+Ang (1–7) (30 µg/kg/day via a mini-osmotic pump),

Group VIII: ISO (5 mg/kg, IP)+Apelin (20 µg/kg, IP)+Ang (1–7) (30 µg/kg/day via a mini-osmotic pump),

Ang (1–7) was obtained from Tocris Bioscience, Apelin from Phoenix Pharmaceuticals, and isoproterenol hydrochloride from Sigma Aldrich, Germany. All injections continued for 10 days. Apelin was administered 30 min before the ISO injection.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!